SCR7 pyrazine is an inhibitor of DNA ligase IV that blocks non-homologous end joining (NHEJ) in a ligase IV‑dependent manner. SCR7 pyrazine enhances the efficiency of Cas9‑mediated homology‑directed repair (HDR). SCR7 pyrazine induces apoptosis and exhibits anticancer activity.
SCR7 is a specific inhibitor of DNA Ligase IV that blocks non-homologous end joining (NHEJ). In mammalian cells and mouse embryos, SCR7 can increase the efficiency of CRISPR/Cas9-mediated, HDR-dependent gene editing by up to 19-fold.
SCR7 effectively inhibits multimer formation at 200 μM and above.
SCR7 efficiently suppresses cell proliferation in MCF7, A549, HeLa, T47D, A2780, HT1080, and Nalm6 cells, with IC50 values of 40, 34, 44, 8.5, 120, 10, and 50 μM, respectively.SCR7 inhibits NHEJ repair of CRISPR-Cas9-induced DSBs.In mammalian cells and mouse embryos, SCR7 increases the efficiency of HDR-mediated gene editing using CRISPR/Cas9.
| 动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
1.An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression.2012 Dec 21;151(7):1474-87. doi: 10.1016/j.cell.2012.11.054
2.Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells.Published: 21 August 2017
| 分子式 C18H12N4OS |
分子量 332.38 |
CAS号 14892-97-8 |
储存方式 -20°C |
| 溶剂(常温) |
DMSO 100 mg/mL |
Water |
Ethanol Slightly |
体内溶解度
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们